Physician profile
Stephen V Laborde
NPI 1962488106
$8,029.06
in general payments reported to CMS, 2019-2025
20 companies · $1,303 in 2025
The $1,303 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $110 · 2021: $1,552 · 2022: $1,576 · 2023: $1,277 · 2024: $1,342 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,210 · Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,210.00 |
| Food and Beverage | $712.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,283.60 | 2023-2025 | |
| Allergan, INC. | $2,920.07 | 2021-2023 | |
| Galderma Laboratories, L.P. | $641.55 | 2019-2025 | Aklief, Epsolay, Oracea |
| Mayne Pharma Commercial LLC | $196.04 | 2019-2023 | |
| Pfizer INC. | $182.07 | 2019-2020 | |
| Incyte Corporation | $141.76 | 2022-2024 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $136.63 | 2019-2025 | Cabtreo, Arazlo, Jublia |
| Amgen INC. | $93.04 | 2022-2024 | Otezla |
| Epi Health, LLC | $91.24 | 2019-2022 | |
| Leo Pharma INC. | $66.80 | 2019-2020 | |
| Journey Medical Corporation | $65.58 | 2019-2023 | |
| Almirall LLC | $36.46 | 2019 | |
| Celgene Corporation | $31.88 | 2019 | |
| Sun Pharmaceutical Industries INC. | $31.07 | 2019-2023 | Winlevi, Absorica Ld |
| Taro Pharmaceuticals USA, INC. | $24.51 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $20.00 | 2019 | |
| Aclaris Therapeutics, INC. | $19.46 | 2019 | |
| Botanix Sb INC | $18.34 | 2025 | Sofdra |
| Dermira, INC. | $17.80 | 2020 | |
| Vyne Pharmaceuticals INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Laborde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.